Research Article

[Retracted] Multivariate Analysis of Recurrence after Hysteroscopic Diagnosis and Treatment of Endometrial Polyps following IVF-ET Failure

Table 2

Comparison of data between recurrent and nonrecurrent patients after surgery for EPs (n (%), mean ± SD).

FactorsnRecurrence group (n = 72)Nonrecurrence group (n = 297)χ 2/t

Age (years old)36930.94 ± 4.4430.52 ± 4.730.6840.495
BMI (kg/m2)4.2900.232
 < 18184 (5.56)14 (4.71)
 18.5–24.931660 (83.33)256 (86.20)
 25–29.9347 (9.72)27 (9.09)
 > 3011 (1.39)0 (0.00)
Complicated with endometriosis19347 (65.28)146 (49.16)6.0360.014
Combined with hydrosalpinx12135 (48.61)86 (28.96)10.1580.001
Complicated with PCOS11831 (43.06)87 (29.29)5.0460.025
Number of polyps6.1920.013
 Single polyp19228 (38.89)164 (55.22)
 Multiple polyps17744 (61.11)133 (44.78)
Polyp size7.2190.007
 < 2 cm in diameter33760 (83.33)277 (93.27)
 ≥ 2 cm in diameter3212 (16.67)20 (6.73)
Surgical methods6.7680.009
 Curettage18426 (36.11)158 (53.20)
 Electrotomy18546 (63.89)139 (46.80)
Postoperative treatment12.7100.002
 No postoperative medication6234 (47.22)28 (9.43)
 1 month of DG administration20031 (43.06)169 (56.90)
 3 months of DG administration1077 (9.72)100 (33.67)

Note. BMI, body mass index; PCOS, polycystic ovarian syndrome; DG, didroxyprogesterone; EPs, endometrial polyps.